Degrasyn (WP1130) is a small molecular deubiquitinase (DUB) inhibitor and suppresses JAK-Stat signaling pathway.
Degrasyn (WP1130) is a small molecular deubiquitinase (DUB) inhibitor and suppresses JAK-Stat signaling pathway.
WRW4 is a selective antagonist of formyl peptide receptor 1 (FPR1) signaling, it inhibits WKYMVm binding to FPR1 (IC50 = 0.23 μM).
WRW4 is a selective antagonist of formyl peptide receptor 1 (FPR1) signaling, it inhibits WKYMVm binding to FPR1 (IC50 = 0.23 μM).
WS-12 (Acoltremon, AR-15512, AVX-012) is a potentially first-in-class, potent TRPM8 agonist with an EC50 of 39 nM. can be used in studies of dry eye and chronic neuropathic pain.
WS-12 (Acoltremon, AR-15512, AVX-012) is a potentially first-in-class, potent TRPM8 agonist with an EC50 of 39 nM. can be used in studies of dry eye and chronic neuropathic pain.
WS-12 (Acoltremon, AR-15512, AVX-012) is a potentially first-in-class, potent TRPM8 agonist with an EC50 of 39 nM. can be used in studies of dry eye and chronic neuropathic pain.
WS-12 (Acoltremon, AR-15512, AVX-012) is a potentially first-in-class, potent TRPM8 agonist with an EC50 of 39 nM. can be used in studies of dry eye and chronic neuropathic pain.
WS3 is a β cell proliferation inducer, which can promote the β cell proliferation of primary rat and human islets. WS3 can be used in the study of type I diabetes.
WS3 is a β cell proliferation inducer, which can promote the β cell proliferation of primary rat and human islets. WS3 can be used in the study of type I diabetes.
WS3 is a β cell proliferation inducer, which can promote the β cell proliferation of primary rat and human islets. WS3 can be used in the study of type I diabetes.
WS6 is a novel beta cell proliferation simulator, which promotes β cell proliferation in rodent and human primary islets with EC50 of 0.28 uM(R7T1 cell viability).